VIDEO: Early treatment with Terlipressin benefits patients with hepatorenal syndrome

In this exclusive video, Andrew Allegretti, MD, MSc, discusses his poster from The Liver Meeting Digital Experience that explored factors associated with response to terlipressin treatment in patients with hepatorenal syndrome.Allegretti, from Massachusetts General Hospital, and colleagues found that IV albumin use and treating earlier in the phase of illness indicated more successful response, while having a precipitating event for the hepatorenal syndrome was predictive of worse outcomes.Read More

Share on facebook
Share on twitter
Share on linkedin